Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001628280-24-003126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-02 | 2024-02-01 | LFCR | Barbarosh Craig A. | Dir | M - OptEx | — | +9,554 | 58.1K | +20% | — |
| DI | 2024-02-02 | 2024-02-01 | LFCR | Barbarosh Craig A. | Dir | M - OptEx | $0.00 | -9,554 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 9,554 | — | 58,073 | I In Trust | — | — | (F1) The restricted Stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Derivative | Restricted Stock Unit | 2024-02-01 | M | D | 9,554 | $0.00 | 0 | I In Trust | — · 2024-02-01 to — | 9,554 Common Stock | (F1) The restricted Stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) The restricted stock units vested on February 1, 2024. |